EP News Bureau

To develop a vaccine against visceral leishmaniasis

The company plans to support India’s aim of achieving 90 per cent coverage through its expanded programme by 2020

The investment will be made in two tranches

Eight therapies have outgrown the IPM growth and all therapies have double digit growths

Looking for suggestions especially on performance assessment of GDUFA and which aspects should be retained, changed, or…

Lubrizol LifeSciences will organise Carbopol Workshop – Oral Formulations

Company posts 10 per cent growth in profit before tax at Rs 88.5 crores

Recognised under the ‘Chemicals and Pharmaceutical category’ for consistent efforts in quality enhancement

The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious disease

The granted claims of the patents include the class of selective 5-HT compounds and are being developed as therapeutic agents